Mainz Biomed partners with Quest for colorectal cancer screening test
Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal cancer screening test,…
Gastrointestinal
-
-
Karmanos Cancer Institute commences prescription of liver cancer device
The Barbara Ann Karmanos Cancer Institute, a part of McLaren Health Care, has commenced the prescription of a new radiofrequency…
-
Natera begins subject enrolment in colon cancer detection test trial
Natera has begun the subject enrolment in the randomised Phase III SAGITTARIUS clinical trial designed to assess the Signatera test…
-
Mursla Bio’s EvoLiver blood test shows promise in HCC surveillance
Mursla Bio has revealed outcomes from the MEV01 clinical study of its ‘EvoLiver’ blood test for the surveillance of hepatocellular…
-
Implantica’s anti-reflux device shows positive two-year results
Implantica has unveiled positive two-year results for its RefluxStop device, an implant designed to manage gastro-oesophageal reflux disease (GORD). Results…
-
Implantica reveals positive results for IEM implant
Implantica has revealed positive results for its RefluxStop implant, a device designed to treat patients with a sub-type of gastro-oesophageal…
-
Mainz Biomed seeks FDA breakthrough device status for colorectal cancer test
Mainz Biomed has submitted an application to the US Food and Drug Administration (FDA) seeking breakthrough device designation for its…
-
RNT Health Insights’ gastric cancer detection tool receives FDA BDD
India-based clinical-stage medical diagnostics company RNT Health Insights has received breakthrough device designation (BDD) from the US Food and Drug…
-
Ambu secures 510(k) clearance for new-generation duodenoscopy solution
Ambu has obtained 510(k) regulatory clearance from the US Food and Drug Administration (FDA) for its new-generation duodenoscopy solution, the…
-
Implantica gears up for FDA approval of acid reflux device
Implantica has started the premarket approval process with the US Food and Drug Administration (FDA) for its gastroesophageal reflux disease…
